Thomas J. Walley
#206,595
Most Influential Person Across History
Thomas J. Walley's AcademicInfluence.com Rankings
Thomas J. Walleymedical Degrees
Medical
#3706
Historical Rank
Pharmacology
#447
Historical Rank
Epidemiology
#642
Historical Rank
Download Badge
Medical Philosophy
Why Is Thomas J. Walley Influential?
(Suggest an Edit or Addition)Thomas J. Walley's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients (2004) (3053)
- The UK General Practice Research Database (1997) (716)
- Outcomes (1995) (376)
- Influences on GPs' decision to prescribe new drugs-the importance of who says what. (2003) (331)
- Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. (2007) (246)
- Why do GPs not implement evidence-based guidelines? A descriptive study. (2001) (230)
- Teaching safe and effective prescribing in UK medical schools: a core curriculum for tomorrow's doctors. (2003) (220)
- Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003. (2005) (192)
- Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality (2004) (186)
- Coronary artery stents: a rapid systematic review and economic evaluation. (2004) (179)
- The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. (2001) (174)
- Comparative efficacy of newer hypnotic drugs for the short‐term management of insomnia: a systematic review and meta‐analysis (2004) (148)
- Variations and increase in use of statins across Europe: data from administrative databases (2004) (139)
- Drug-eluting stents: an early systematic review to inform policy. (2004) (138)
- Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. (2003) (132)
- Economic evaluation under managed competition: evidence from the U.K. (1997) (130)
- Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses (2011) (111)
- Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. (2004) (108)
- Monitoring Financial Flows for Health Research. Geneva: Global Forum for Health Research, World Health Organization, 2001. 57pp. ISBN 2-940286- 05-1. [The full text is available on the web site http://www.globalforumhealth.org] (2002) (107)
- The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. (2008) (107)
- The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: A systematic review* (2009) (106)
- Reporting of adverse drug reactions by nurses (2003) (102)
- The Iranian Health Insurance System; Past Experiences, Present Challenges And Future Strategies (2012) (101)
- Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. (1996) (99)
- Data protection legislation: interpretation and barriers to research (2000) (93)
- Interaction of metoprolol and fluoxetine (1993) (88)
- Alterations in prescribing by general practitioner fundholders: an observational study (1995) (81)
- Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost–utility study (2005) (81)
- Clinical guidelines—the hidden costs (1999) (79)
- Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review. (2003) (70)
- Epidemiology of restless legs syndrome as diagnosed in UK primary care. (2004) (69)
- Medication errors in primary care in Riyadh City, Saudi Arabia. (2011) (69)
- The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review. (2011) (69)
- The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation. (2010) (67)
- Drug-eluting stents: a systematic review and economic evaluation. (2007) (67)
- New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach. (2003) (64)
- A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing. (2005) (61)
- Understanding why GPs see pharmaceutical representatives: a qualitative interview study. (2003) (60)
- Influences of practice characteristics on prescribing in fundholding and non-fundholding general practices: an observational study (1996) (59)
- Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials (2021) (58)
- Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies. (2006) (57)
- New drug prescribing by hospital doctors: the nature and meaning of knowledge. (2006) (57)
- Using drugs safely (2002) (54)
- Pharmacoeconomics: basic concepts and terminology. (1997) (54)
- Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation. (2009) (53)
- Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma. (2009) (52)
- Developing a core curriculum in clinical pharmacology and therapeutics: a Delphi study. (2003) (50)
- Health technology assessment in England: assessment and appraisal (2007) (49)
- Health Care Financing In Iran; Is Privatization A Good Solution? (2012) (48)
- Erlotinib for the treatment of relapsed non-small cell lung cancer. (2009) (46)
- Regulating pharmaceutical markets: improving efficiency and controlling costs in the UK. (2005) (45)
- Loperamide related toxic megacolon in Clostridium difficile colitis. (1990) (45)
- An alternative to body mass index for standardizing body weight for stature. (2000) (44)
- Lifestyle medicines (2000) (43)
- Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels (2006) (41)
- Clinical guidelines: development, implementation, and effectiveness. (1995) (41)
- Accounting for Noncompliance in Pharmacoeconomic Evaluations (2012) (41)
- Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes. (2005) (41)
- Clinical pharmacology and therapeutics in undergraduate medical education in the UK: current status. (1994) (40)
- Effects of a monetary incentive on primary care prescribing in Ireland: changes in prescribing patterns in one health board 1990–1995 (2000) (40)
- Do quality incentives change prescribing patterns in primary care? An observational study in Scotland. (2008) (39)
- Pharmaceutical policy and market in Iran: past experiences and future challenges (2011) (38)
- Core content of a course in clinical pharmacology. (2003) (38)
- Using personal health information in medical research (2006) (37)
- Introducing new health interventions (2006) (37)
- Addressing barriers to change: an RCT of practice-based education to improve the management of hypertension in the elderly. (1999) (35)
- Opioids in Italy: is marketing more powerful than the law? (2003) (35)
- Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma. (2007) (34)
- Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK. (2003) (34)
- Sumatriptan Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in the Acute Treatment of Migraine and Cluster Headache (1992) (34)
- Local clinical guidelines: description and evaluation of a participative method for their development and implementation. (1996) (32)
- The management of hypertension in the elderly by general practitioners in Merseyside: the rule of halves revisited. (1998) (32)
- Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe (2004) (31)
- An integrated national pharmaceutical policy for the United Kingdom? (2000) (30)
- Pharmacoeconomics: integrating economic evaluation into clinical trials. (1997) (30)
- Treatment for Newly Diagnosed Hypertension: Patterns of Prescribing and Antihypertensive Effectiveness in the UK (2003) (29)
- Predicting “real world” effectiveness by integrating adherence with pharmacodynamic modeling (2003) (29)
- Clinical pharmacology and therapeutics in undergraduate medical education in the UK: the future. (1994) (28)
- Effect of the calcium antagonist nifedipine on intraocular pressure in normal subjects. (1988) (28)
- Average daily quantities: a tool for measuring prescribing volume in England (2000) (28)
- Evaluating laboratory diagnostic tests (2008) (27)
- A study of the appropriateness of prescribing in nursing homes (1997) (27)
- Pharmacoeconomics: a challenge for clinical pharmacologists. (1995) (27)
- A randomized trial of Evidence-based OutReach (EBOR): rationale and design. (1999) (27)
- A purchaser perspective of managing new drugs: interferon beta as a case study (1995) (27)
- Economic evaluation in health care decision making (1996) (26)
- EURO-MED-STAT: monitoring expenditure and utilization of medicinal products in the European Union countries: a public health approach. (2003) (25)
- A pilot study assessing the effectiveness of a decision aid on patient adherence with oral bisphosphonate medication (2006) (25)
- Investigating Consumer Perspectives on Evaluating Health Technologies (2001) (25)
- Economic evaluations of drug therapy: attitudes of primary care prescribing advisers in Great Britain. (1997) (25)
- [Medication prescribing pattern in primary care in Riyadh City, Saudi Arabia] (2011) (24)
- Metipranolol-induced adverse reactions: I. The rechallenge study (1992) (23)
- Selective serotonin reuptake inhibitors. (1992) (23)
- The association of some practice characteristics with antibiotic prescribing (1999) (23)
- Evidence-informed evidence-making (2008) (23)
- Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers. (1987) (23)
- Physicians' medication prescribing in primary care . in Riyadh City, Saudi Arabia. Literature review, part 3: prescribing errors. (2011) (22)
- Physicians' medication prescribing in primary care in Riyadh City, Saudi Arabia. Literature review, part 2: rational prescribing. (2011) (22)
- Economic Evaluations During Early (Phase II) Drug Development (2012) (21)
- Rational prescribing in primary care--a new role for clinical pharmacology? (1993) (21)
- Financial incentives and prescribing (2004) (21)
- Determinants of physicians' medication prescribing behaviour in primary care in Riyadh City, Saudi Arabia. (2011) (20)
- Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin. (2003) (20)
- Trends and influences on use of antidiabetic drugs in England, 1992–2003 (2005) (20)
- Angioplasty and stents in coronary artery disease: a systematic review and meta‐analysis (2004) (20)
- Pharmaceutical Pricing in Europe: Weighing Up the Options (2006) (20)
- Economic evaluation in health care decision making: evidence from the UK (1996) (19)
- Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation. (2007) (19)
- Generic prescribing: time to regulate the market? (2000) (19)
- Nitrite-induced methaemoglobinaemia. (1987) (19)
- Risk Sharing and Payment by Results (2008) (19)
- A reliability study of an instrument for measuring general practitioner consultation skills: the LIV-MAAS scale. (2003) (19)
- Review of therapeutically equivalent alternatives to short acting β2 adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers (1999) (18)
- Availability of medicines in the European Union: results from the EURO-Medicines project (2001) (18)
- Case study of the comparison of data from conference abstracts and full-text articles in health technology assessment of rapidly evolving technologies: Does it make a difference? (2006) (18)
- Physicians medication prescribing in primary care in Riyadh City, Saudi Arabia. Literature review, part 1: variations in drug prescribing. (2011) (18)
- Neuropsychotherapeutics in the UK (2004) (18)
- Measuring consultation skills in primary care in England: evaluation and development of content of the MAAS scale. (2002) (17)
- The management of Pneumocystis carinii pneumonia. (1999) (17)
- Pharmacoeconomics: evaluating the evaluators. (1997) (17)
- General practice fundholders' prescribing savings in one region of the United Kingdom, 1991-1994. (1997) (17)
- Provider incentives and prescribing behavior in Europe (2005) (16)
- Prescription charges: change overdue? (1998) (16)
- Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian region. (2006) (16)
- Trends in primary care antibiotic prescribing in England 1994–1998 (2001) (16)
- Using Comparative Effectiveness Research to Inform Policy and Practice in the UK NHS (2012) (16)
- Supply and regulation of medicines (2005) (16)
- The UK Indicative Prescribing Scheme (1992) (15)
- Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non-fundholders. (1999) (15)
- Effects of Calcium Channel Blockers on In Vitro Platelet Function in Whole Blood Using Single Platelet Counting (1989) (15)
- Prescribing costs in general practice fundholding (1995) (15)
- Drugs, money and society. (1995) (15)
- Integrating clinical pharmacology in a new problem based medical undergraduate curriculum. (1997) (14)
- Effectiveness of three interventions on primary care physicians' medication prescribing in Riyadh City, Saudi Arabia. (2011) (14)
- Medicines Regulation and Health Technology Assessment (2010) (14)
- Patients' expectations of medicines – a review and qualitative synthesis (2016) (13)
- Perceptions of the impact of primary care organizations on GP prescribing: the iron fist in the velvet glove? (2013) (13)
- HEALTH CARE CHALLENGES IN IRAN (2005) (13)
- Prescribing at the Interface Between Primary and Secondary Care in the UK (1999) (12)
- Superiority and equivalence in thrombolytic drugs: an interpretation. (2003) (12)
- Using disease registries for pharmacoepidemiological research: a case study of data from a cystic fibrosis registry (2003) (12)
- The influence of practice characteristics on the prescribing of benzodiazepines and appetite suppressant drugs (1998) (12)
- Predictors of quality of medication prescribing in primary care in Riyadh City, Saudi Arabia. (2011) (12)
- Hypertension in the elderly: attitudes of British patients and general practitioners (1998) (12)
- FHSA medical advisers: friends or foes? (1992) (12)
- The qualitative experience of telehealth access and clinical encounters in Australian healthcare during COVID-19: implications for policy (2021) (11)
- ‘All the stars were aligned’? The origins of England’s National Institute for Health Research (2019) (11)
- The NIHR at 10: transforming clinical research . (2016) (11)
- Reporting of adverse drug reactions: practice in the UK. (1998) (11)
- Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants (2007) (11)
- Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. (2002) (10)
- Research funding in a pandemic (2010) (10)
- Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia (2018) (10)
- Auditing the management of hypertension in British general practice: a critical literature review. (1998) (9)
- Reconciling national treatment policies and drug regulation in Kenya. (2007) (9)
- Lifestyle Medicines and the Elderly (2002) (9)
- A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC) (2011) (8)
- Current Prescribing in Primary Care in the UK (1995) (8)
- Davies Textbook of Adverse Drug Reactions. (2000) (7)
- Acute inotropic effects of intravenous nifedipine and its vehicle compared with saline: a double-blind study of systolic time intervals in normal subjects. (1988) (7)
- The pros and cons of essential medicines for rich countries (2004) (7)
- Early Access to New Medicines (2008) (7)
- Reproducibility and comparison of cardiac output measurement by transthoracic bioimpedance and thermodilution methods in critically ill patients. (1993) (7)
- Topical NSAIDs are better than placebo (1998) (7)
- Translating Comparative Effectiveness Research into Clinical Practice (2012) (7)
- Health Economics in Primary Care in the UK (1993) (7)
- A Practical Guide to Meat Inspection (1890) (6)
- Proceedings of the 4th World Conference on Research Integrity (2016) (6)
- Publicly funded practice-oriented clinical trials: of importance for healthcare payers. (2016) (6)
- Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients. (1993) (6)
- Clinical Effectiveness and Clinical Governance Made Easy. (2001) (6)
- Developments for funding clinical research in the UK (2008) (6)
- The clinical effectiveness and cost-effectiveness of testing for cytochrome P 450 polymorphisms in patients with schizophrenia treated with antipsychotics : a systematic review and economic evaluation (2009) (6)
- The European Community dimension : coordinating divergence (2004) (6)
- Challenges in changing to non-chlorofluorocarbon inhalers in the treatment of asthma (1999) (6)
- The UK indicative prescribing scheme: background and operation. (1992) (6)
- The future challenges (2004) (5)
- Comparison of thermodilution, thoracic electrical bioimpedance and Doppler ultrasound cardiac output measurement. (1994) (5)
- The Impact of Health Economics on Healthcare Delivery (2012) (5)
- Eye pain with nifedipine (1988) (5)
- Is there a Need for an Independent Centre for Pharmacoeconomics in the UK? (1994) (5)
- Pharmacoeconomics Comes of Age? (2008) (5)
- Influences of practice characteristics on prescribing in practices. (1996) (5)
- The UK's NHS and pharma: need for more clinical pharmacologists (2009) (5)
- How evidence is reviewed. (2001) (5)
- THE USE OF HEALTH ECONOMICS BY HOSPITAL PHARMACIST DECISION MAKERS : A SURVEY OF UK CHIEF PHARMACISTS (1997) (5)
- Miscellaneous antibacterial drugs (1995) (5)
- Benefit of statins in daily practice? A six-year retrospective observational study. (2009) (5)
- Drug Rationing in the UK National Health Service (1997) (4)
- Allergy to penicillin (1991) (4)
- Autoregulation of tissue blood flow in essential hypertension. (1985) (4)
- A UK National Prescribing List? (1995) (4)
- Nifedipine infusion in acute myocardial infarction: Experience in twelve patients (1987) (4)
- The EurMedStat proposals on indicators for price and utilisation (2006) (4)
- Fair pricing for medicines in the UK (2007) (4)
- Upper gastrointestinal endoscopy (1995) (4)
- Managing the entry of new medicines in the National Health Service: health authority experiences and prospects for primary care groups and trusts. (2001) (4)
- Drugs, money and society (Part II). (2010) (4)
- Effects of a monetary incentive on primary care prescribing in Ireland: Attitudes and perceptions of healthcare professionals and patients (2001) (4)
- Atypical Antipsychotic Prescribing Patterns in an Italian District 2001-2009 and the Impact of Regulatory Warnings (2014) (4)
- Why health economics matter (1999) (4)
- District health care: Challenges for planning, organisation and evaluation in developing countries, 2nd edition: R. Amonoo-Lartson, G. J. Ebrahim, H. J. Lovel & J. P. Ranken. London and Basingstoke: Macmillan Education Ltd, 1996. vii+296pp. Price £10.50. ISBN 0-333-57349-8 (1996) (4)
- A novel approach to sharing all available information from funded health research: the NIHR Journals Library (2018) (3)
- Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials (2012) (3)
- Adverse effects of captopril in hospital outpatients with hypertension. (1990) (3)
- Research to decrease areas of clinical uncertainty (2011) (3)
- Searching for and use of conference abstracts in health technology assessments: Policy and practice (2006) (3)
- “Slurry lung”: a report of three cases (1991) (3)
- Outcomes, Outcomes Research and Disease Management (1999) (3)
- Study did not take account of confounders (1996) (3)
- Independent and Supplementary Prescribing: Psychology and sociology of prescribing (2010) (3)
- Commercialisation of disease management (1996) (3)
- Approaches to pharmacoeconomic analysis (2004) (3)
- Health technology assessment--the role of the pharmaceutical panel. (1998) (3)
- Medical pharmacology : a clinical core text for integrated curricula with self-assessment (2002) (3)
- Effective contracting of high-tech health care for patients at home. (1996) (3)
- Call for flu research under way (2009) (2)
- Medical therapeutics (1996) (2)
- Development of an Economic Model for the Management of Upper Gastrointestinal Disease in Primary Care (2012) (2)
- The patient experience of telehealth access and clinical encounters in Australian health care during COVID-19: implications for enhancing integrated care (2022) (2)
- The effects of intravenous and oral nifedipine on ex vivo platelet function (2004) (2)
- The future of health research in the UK (2006) (2)
- Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal” (2022) (2)
- INTERACTION OF METROPOLOL AND FLUOXETINE (1993) (2)
- Different vasodilating mechanisms--different peripheral effects? (1992) (2)
- Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland (2006) (2)
- Penetrating Wounds of the Horse's Foot (2)
- The risk of cardiovascular disease in hypertensive patients. (1997) (2)
- PMDP4: THE INFLUENCE OF NON-COMPLIANCE ON THE EFFECTIVENESS AND COST-EFFECTIVENESS OF DRUG THERAPIES (2000) (2)
- Direct to consumer marketing: Switch to over the counter can become indirect advertising directly to consumers (2005) (2)
- The four bovine scourges: pleuro-pneumonia, foot-and-mouth disease, cattle plague, tubercle (scrofula) (2)
- Cost implications of prehospital emergency drug administration. The case of prehospital thrombolytics. (1996) (2)
- Clinical statistics (1996) (2)
- Seral antibiotics at home in cystic fibrosis: iences and attitudes of recipients (2007) (2)
- Pharmacoeconomics for migraine and headache researchers: basic concepts, methods and terminology (2004) (2)
- Effects of fundholding on prescribing habits (1996) (2)
- Diseased Meat (1871) (1)
- Clinical guidelines: ways ahead. (1998) (1)
- Therapeutic Conservatism (1994) (1)
- Technical difficulties may have affected study's results (1996) (1)
- PNM18 COST-EFFECTIVENESS OF Z DRUGS (ZOLPIDEM, ZOPICLONE AND ZALEPLON) VERSUS BENZODIAZEPINES FOR THE SHORT—TERM MANAGEMENT OF INSOMNIA: A SYSTEMATIC LITERATURE REVIEW (2003) (1)
- Health technology assessment: A potential roadmap for India - (2017) (1)
- Tuberculosis in Milk (1889) (1)
- Extent of uncollected prescriptions in general practice (2007) (1)
- Exploring groups at high risk of restenosis (2004) (1)
- Price Indicators The Library of European Union Pharmaceutical Indicators The EUROMED-STAT Group (2005) (1)
- Modelling in health economics (2004) (1)
- Nifedipine Infusion in Acute Myocardial Infarction; Experience in Twelve Patients (1988) (1)
- Cost Implications of Prehospital Emergency Drug Administration (1996) (1)
- Drug interactions with OTCs. (1991) (1)
- The EuroMedicines Project (2003) (1)
- The haemodynamic effects of intravenous nifedipine in normotensive and hypertensive subjects. (1988) (1)
- Importance of health economics must be recognised when trials are designed (1999) (1)
- Drug‐eluting stents versus non‐drug eluting stents in people with stable angina or acute coronary syndrome (2004) (1)
- 'This house believes that pharmacoeconomic analysis should be mandated by governments rather than left to market forces'. (1994) (1)
- Generic Substitution (1993) (1)
- THE MEDICAL AND VETERINARY SCIENCES. (1888) (1)
- ASSESSING THE VALUE OF HEALTHCARE INNOVATIONS: A PROPOSAL FOR AN INTEGRATED HTA-RIH APPROACH IN THE 'NEW NORMAL'. (2022) (1)
- Liver disease in cattle (1)
- Outcomes Research and Biotechnology Products: A European View (2000) (1)
- Patient packs and the prescribing of antimicrobial agents. (1996) (1)
- Contracting for high-tech health care for patients at home: a survey of purchaser responses. (1996) (0)
- Commentary: Research to decrease areas of clinical uncertainty (2011) (0)
- The Prophylaxis of Canine Distemper (1890) (0)
- The Clinical and Scientific Basis of Drug Toxicity (1990) (0)
- Public policy and the Austrian pharmaceutical market: options for reform (2005) (0)
- Treatment of gastro-oesophageal reflux disease in adults. "Step down" strategy of treatment would be expensive. (1999) (0)
- When OTC marketing becomes direct to consumer advertising (2005) (0)
- Erlotinib in non-small cell lung cancer - Single Technology Appraisal (2006) (0)
- Malignant aphtha in Sheep (0)
- A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice (2002) (0)
- Prescribing for the management of risk : towards a theoretical understanding (2015) (0)
- The public policy context for pharmacoeconomics (2004) (0)
- Clinical research in the National Health Service in England. (2009) (0)
- II.Clinical pharmacology andtherapeutics inundergraduate medical education intheUK:thefuture (1994) (0)
- Setting the research agenda for future clinical trials on the use of biologics in rheumatology. (2011) (0)
- Comparison of Ejection Fraction (EF) Measured by Transthoracic Electrical Bioimpedance (TEB) and Multi-Gated Radionuclide (MUGA) Scanning in Patients (1992) (0)
- Effects of Metoprolol on Plasma Concentrations and Pharmacodynamics of Intravenous Nifedipine (1987) (0)
- Society for Social Medicine and the International Epidemiological Association European Group (2001) (0)
- Adverse effects ofcaptopril inhospital outpatients with hypertension (1990) (0)
- Case of Poisoning by Scrophularia Nodosa, or Knotted Figwort, in a Cow (0)
- DIPHTHERIA IN MAN AND THE LOWER ANIMALS. (1887) (0)
- Porcine Pneumo-Enteritis and Human Enteric Fever (1889) (0)
- Health Technology Assessment and patient safety (2005) (0)
- Muscular Lesions in the Horse (0)
- Therapeutic Conservatism (1993) (0)
- Introduction to CYP2D6 and CYP2D6 testing (2011) (0)
- An independent centre for pharmacoeconomics in the UK (1995) (0)
- Clinical guidelines (1995) (0)
- Pharmacoeconomics (2018) (0)
- A THREATENED EPIDEMIC OF HYDROPHOBIA. (1885) (0)
- Animal Tuberculosis in Relation to Consumption in Man (1888) (0)
- Impact of medicines on Public Health: EURO-MED-STAT (2004) (0)
- Pre-Hospital Thrombolysis: The Author’s Reply (1997) (0)
- Hints on the Breeding and Rearing of Farm Animals (2013) (0)
- Re: 'Diagnostics may well be a Cinderella, but not of health technology assessment (2017) (0)
- Direct to consumer marketing (2005) (0)
- Spermatic Aneurismal Varix in the Ox (0)
- Pharmacometric analysis of duration of drug action: implications for improved forgiveness to medication non-compliance (2001) (0)
- Tuberculosis, its Diagnosis, Sanitary Aspect, Etc. (0)
- BONE-SOFTENING IN GOATS. (1889) (0)
- Health care policy (1995) (0)
- Consumer contributions to health technology assessment (2001) (0)
- The Office of Fair Trading report clearly shows that the current system is flawed and cannot carry on (2007) (0)
- WILL ANTIBIOTICS AFFECT MY SPORTING PERFORMANCE (1998) (0)
- Dobbs’ study (2003) (0)
- Donepezil and Alzheimer's dementia. (2000) (0)
- Impedance cardiography. (1993) (0)
- Uncertainties page: Research to decrease areas of clinical uncertainty (2011) (0)
- Exploring groups at high risk of restenosis (letter) (2004) (0)
- WITHDRAWAL OF ANTIHYPERTENSIVE DRUGS (1997) (0)
- Notes on some Interesting Cases (0)
- The management ofhypertensionintheelderly by generalpractitioners inMerseyside:therule of halvesrevisited (1998) (0)
- Substrate effects in prostaglandin biosynthesis in vesicular membranes [proceedings]. (1977) (0)
- British Medical Journal (1878) (0)
- Healthcare management (1997) (0)
- The Dangers of Cow's Milk Immediately After Parturition (0)
- Ejection fraction by transthoracic electrical bioimpedance : reproducibility and comparison with multi-gated radionuclide scan (1993) (0)
- PROLAPSE OF THE WALL OF THE STOMACH OF A HORSE INTO THE DUODENUM. (1890) (0)
- Lack of pharmacodynamic interactions between acute dose flosequinan and xamoterol (2004) (0)
- Haemodynamic Effects of Intravenous Nifedipine in Hypertensive and Normotensive Subjects (1988) (0)
- Malpositions of the Colon (1892) (0)
- Bayer promotional publications misleading about effect of ciprofloxacin on hospital admissions (1995) (0)
- Animal Tuberculosis in Relation to Consumption in Man (0)
- Cytochrome P450 genotyping: the UK perspective (2007) (0)
- A practical guide to meat inspection (Walley) (0)
- Cross-sectional echocardiography in the diagnosis of Libman-Sachs endocarditis. (1988) (0)
- Stents versus coronary artery bypass graft in people with stable angina or acute coronary syndrome (2004) (0)
- Animal Tuberculosis in Relation to Consumption in Man (1888) (0)
- HYDATID DISEASE IN ITS CLINICAL ASPECTS. (1891) (0)
- Impedance cardiography [letter; comment] (1993) (0)
- ACE inhibitors and peripheral vascular disease (1990) (0)
- Authors' reply (1996) (0)
- Ophthalmia (1903) (0)
- Comparative Pathology. (0)
- Reproducibility and Changes in Ejection Fraction (EF) Measured by Transthoracic Electrical Bioimpedance (TEB) in Healthy Subjects (1992) (0)
- Current Controversies in Therapeutics (1992) (0)
- Interesting clinical cases (0)
- The Differentiation in the Characters and Symptoms of Gastro-Intestinal Affections (1875) (0)
- Putrefactive Processes in Relation to Disease (0)
- Dictionary of pharmacoepidemiology (2001) (0)
- Report on VI World Congress on Clinical Pharmacology and Therapeutics, Buenos Aires, 4–9 August 1996 (1997) (0)
- Feasibility study of multicentre comparison of NHS hospital pharmacy computer data. (2000) (0)
- Health economics for developing countries: a practical guide - S. Witter, T. Ensor, M. Jowett & R. Thompson. London and Oxford: Macmillan Education, 2000. viii+296pp. Price @$7.50. ISBN 0-333-75205-8 (2001) (0)
- Clinical and pathological notes (0)
- Should health economics fall within the remit of the physician (1997) (0)
- The Tuberculosis Question (1889) (0)
- PCV36 COST-EFFECTIVENESS OF EARLY THROMBOLYSIS FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW OF THE LITERATURE (2003) (0)
- Pemetrexed in non-small cell lung cancer: Single technology appraisal (2006) (0)
- American Pleuro-Pneumonia (0)
- Correspondence (1874) (0)
- Diagnostics is not Cinderella of health technology assessment (2006) (0)
- Antibiotic Guidelines (1993) (0)
- Therapeutic Conservatism (1993) (0)
- The operation of the pleuro-pneumonia act (0)
- Rational prescribing in primary care. A role for clinical pharmacology in Europe? (1998) (0)
- Digest of evidence ... pramipexole and Parkinson's disease. (2000) (0)
- Pharmacokinetics and Dynamics of Intravenous Infusion of Nifedipine in a Dose Ranging Study (1986) (0)
- The economics of healthcare and healthcare systems (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas J. Walley?
Thomas J. Walley is affiliated with the following schools:
